Report Publication Announcement • Mar 20, 2023
Report Publication Announcement
Open in ViewerOpens in native device viewer
Issoire (France), March 20th, 2023, 6:00 pm CET – BIOCORP (FR0012788065 – ALCOR / Eligible PEA-PME), a French company specialized in the design, development, and manufacturing of innovative medical devices, presents its financial reporting schedule for 2023(1).
| Annonce | Date* |
|---|---|
| 2022 full-year results | Wednesday, March 29th, 2023 Before the market opening |
| Annual shareholders meeting | Tuesday, May 16th, 2023 |
| 2023 first-half results | Thursday, September 28th, 2023 Before the market opening |
(1) This schedule is indicative and subject to change.
Recognized for its expertise in the development and manufacture of medical devices and delivery systems, BIOCORP has today acquired a leading position in the connected medical device market thanks to Mallya. This smart sensor for insulin injection pens allows reliable monitoring of injected doses and thus offers better compliance in the treatment of patients with diabetes. Available for sale from 2020, Mallya spearheads BIOCORP's product portfolio of innovative connected solutions. The company has 80 employees. BIOCORP is listed on Euronext since July 2015 (FR0012788065 – ALCOR). For more information, please visit www.biocorpsys.com.
CONTACTS BIOCORP
Jacques Gardette Éric Dessertenne Sylvaine Dessard [email protected] [email protected]
Chairman of the Board Chief Executive Officer Marketing & Communication Director + 33 (0)6 88 69 72 85
CONTACTS ULYSSE COMMUNICATION Bruno Arabian Margaux Puech [email protected] [email protected] +33 (0)6 87 88 46 26 +33 (0)7 86 16 01 09
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.